Prevalence of Antiretroviral Drug Resistance and Resistance-Associated Mutations in Antiretroviral Therapy-Naïve HIV-Infected Individuals from 40 United States Cities
- 1 February 2007
- journal article
- research article
- Published by Taylor & Francis in HIV Research & Clinical Practice
- Vol. 8 (1) , 1-8
- https://doi.org/10.1310/hct0801-1
Abstract
Background: Transmission of drug-resistant HIV strains to antiretroviral therapy (ART)-naïve subjects can negatively impact therapy response. As treatment strategies and utilization of antiretroviral drugs evolve, patterns of transmitted mutations may shift. Method: Paired genotypic and phenotypic susceptibility data were retrospectively analyzed for 317 ART-naïve, HIV–infected subjects from 40 small and major metropolitan cities in the Northeastern, Midwestern, Southern, Southwestern, and Northwestern United States during 2003. Results: Using current (January 2007) PhenoSense cutoffs, HIV-from 8% of subjects had reduced susceptibility to ⩾1 drug. By class, >% had reduced susceptibility to protease inhibitors (PIs), and % had reduced susceptibility to nucleoside reverse transcriptase inhibitors (NRTIs); reduced susceptibility to ⩾1 non–nucleoside reverse transcriptase inhibitor (NNRTIs) was seen in 7% of subjects, with 4% of all subjects having reduced susceptibility to all NNRTIs. IAS–USA–defined NRTI, NNRTI, and/or major PI HIV–drug resistance–associated mutations were detected for 0% of the subjects. HIV risk factors included homosexual contact (74%), heterosexual contact (28%), and injectable drug use/transfusion/other (7%.Reduced susceptibility to ⩾1 drug was significantly higher (p = .034) for white subjects than African Americansand Hispanics/others. Conclusion: The high prevalence of drug resistance in these ART–naïve subjects suggests thattransmitted resistance is occurring widely within the United States. HIV genotyping and/or phenotyping for antiretroviral-naïve patients seeking treatment should be considered, especially if the therapy will include an NNRTI. PDF Keywords antiretroviral naïve, HIV, prevalence, reduced susceptibility, resistance, transmission Related articles View all related articles var addthis_config = { ui_cobrand: "Taylor & Francis Online", services_compact: "citeulike,netvibes,twitter,technorati,delicious,linkedin,facebook,stumbleupon,digg,google,more", pubid: "ra-4dff56cd6bb1830b" }; var addthis_config = {"data_track_addressbar":true,"ui_click":true}; Add to shortlist Link Permalink http://dx.doi.org/10.1310/hct0801-1 Download Citation Recommend to: A friendKeywords
This publication has 16 references indexed in Scilit:
- Prevalence of Transmitted HIV-1 Drug Resistance and the Role of Resistance AlgorithmsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Early Virologic Nonresponse to Tenofovir, Abacavir, and Lamivudine in HIV‐Infected Antiretroviral‐Naive SubjectsThe Journal of Infectious Diseases, 2005
- Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in GreeceVirus Research, 2005
- Antiretroviral Recommendations May Influence the Rate of Transmission of Drug‐Resistant HIV Type 1Clinical Infectious Diseases, 2005
- 'Working at the margins' or 'leading from behind'?: a Canadian study of hospital-community collaborationHealth & Social Care in the Community, 2005
- Drug-Resistant HIV Infection among Drug-Naive Patients in IsraelClinical Infectious Diseases, 2005
- The Epidemiology of Antiretroviral Drug Resistance among Drug‐Naive HIV‐1–Infected Persons in 10 US CitiesThe Journal of Infectious Diseases, 2004
- Antiretroviral Drug Resistance Mutations in Antiretroviral‐Naive PrisonersClinical Infectious Diseases, 2002
- Antiretroviral-Drug Resistance among Patients Recently Infected with HIVNew England Journal of Medicine, 2002
- Managing Resistance to Anti-HIV DrugsDrugs, 1999